{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:32:11Z","timestamp":1787772731026,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Psoriasis begins in childhood in around one-third of the cases. There has been conflicting evidence regarding the association of paediatric psoriasis with comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>The objective of this study was to find out various comorbidities (abnormal body mass index, metabolic syndrome, lipid abnormalities, diabetes mellitus, and raised blood glucose) associated with paediatric psoriasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>All patients of psoriasis (age &lt;18 years) who visited the Paediatric Psoriasis clinic from January 2017 to September 2021 were recruited in this record-based study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Records of 100 patients were analysed, with female to male ratio of 1:1. The age group ranged from 11 months to 18 years. The average body surface area involved was 5.43%. The average psoriasis area and severity index was 2.47. Joint involvement was seen in 7% of patients in our study. A total of 52 (52%) patients had abnormal body mass index, out of which 21 patients were overweight and 31 were obese. At least one lipid abnormality was found in 66 (66%) patients. The most common lipid abnormality was decreased high-density lipoprotein, followed by raised total cholesterol, raised total triglycerides and raised low-density lipoprotein. 8 (8%) patients were found to have raised blood glucose levels. Out of which, six had impaired fasting glucose and two were diagnosed with diabetes mellitus. 5 (5%) patients were diagnosed with metabolic syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Paediatric psoriasis is a chronic disfiguring disease and may have profound emotional and psychological effects. There is a lack of studies from India on the prevalence of these comorbidities in paediatric psoriasis. More studies are required from different parts of the world for a better understanding of paediatric psoriasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_276_23","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T17:14:08Z","timestamp":1724951648000},"page":"492-496","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Comorbidities in Paediatric Psoriasis"],"prefix":"10.4103","volume":"68","author":[{"given":"Vibhu","family":"Mendiratta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharati","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashna","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20240829","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R2-2-20240829","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/healthcare10071190","article-title":"Metabolic comorbidities and cardiovascular disease in pediatric psoriasis: A narrative review","volume":"10","author":"Marani","year":"2022","journal-title":"Healthcare (Basel"},{"key":"R3-2-20240829","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/pde.14208","article-title":"Pediatric psoriasis and association with cardiovascular and metabolic comorbidities: Systematic review and meta-analysis","volume":"37","author":"Phan","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"R4-2-20240829","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.arcped.2018.12.005","article-title":"Psoriasis and metabolic and cardiovascular comorbidities in children: A systematic review","volume":"26","author":"Badaoui","year":"2019","journal-title":"Arch Pediatr"},{"key":"R5-2-20240829","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","article-title":"The metabolic syndrome in children and adolescents-an IDF consensus report","volume":"8","author":"Zimmet","year":"2007","journal-title":"Pediatr Diabetes"},{"key":"R6-2-20240829","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/ped.13309","article-title":"Pediatric psoriasis: Should we be concerned with comorbidity? Cross-sectional study","volume":"59","author":"Kelati","year":"2017","journal-title":"Pediatr Int"},{"key":"R7-2-20240829","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaad.2019.08.049","article-title":"Joint american academy of Dermatology-national psoriasis foundation guidelines of care for the management and treatment of psoriasis in pediatric patients","volume":"82","author":"Menter","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R8-2-20240829","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1525-1470.1994.tb00563.x","article-title":"A survey of childhood psoriasis in Kuwait","volume":"11","author":"al-Fouzan","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"R9-2-20240829","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-4632.2004.02182.x","article-title":"Epidemiology of childhood psoriasis: A study of 419 patients from northern India","volume":"43","author":"Kumar","year":"2004","journal-title":"Int J Dermatol"},{"key":"R10-2-20240829","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1525-1470.1990.tb01067.x","article-title":"Childhood psoriasis: An epidemiologic survey of 112 patients","volume":"7","author":"Nanda","year":"1990","journal-title":"Pediatr Dermatol"},{"key":"R11-2-20240829","first-page":"ii14","article-title":"Psoriatic arthritis: Epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R12-2-20240829","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40257-017-0294-9","article-title":"Pediatric psoriasis","volume":"18","author":"Relvas","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"R13-2-20240829","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12969-016-0075-7","article-title":"Familial autoimmunity in the childhood arthritis and rheumatology research alliance registry","volume":"14","author":"Prahalad","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"R14-2-20240829","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2009.09593.x","article-title":"Epidemiology and comorbidity of psoriasis in children","volume":"162","author":"Augustin","year":"2010","journal-title":"Br J Dermatol"},{"key":"R15-2-20240829","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2133.2009.09276.x","article-title":"Overweight and childhood psoriasis","volume":"161","author":"Boccardi","year":"2009","journal-title":"Br J Dermatol"},{"key":"R16-2-20240829","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamadermatol.2013.1078","article-title":"Association of pediatric psoriasis severity with excess and central adiposity: An international cross-sectional study","volume":"149","author":"Paller","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R17-2-20240829","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamadermatol.2017.0499","article-title":"Pediatric psoriasis comorbidity screening guidelines","volume":"153","author":"Osier","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R18-2-20240829","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The 'psoriatic march': A concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp Dermatol"},{"key":"R19-2-20240829","first-page":"e18397","article-title":"Screening for comorbid cardiovascular risk factors in pediatric psoriasis among Iraqi patients: A case-control study","volume":"13","author":"Dhaher","year":"2021","journal-title":"Cureus"},{"key":"R20-2-20240829","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/ijd.14805","article-title":"Association of metabolic syndrome with pediatric psoriasis: A case-control study in Kabul, Afghanistan","volume":"59","author":"Aalemi","year":"2020","journal-title":"Int J Dermatol"},{"key":"R21-2-20240829","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/bjd.12441","article-title":"Childhood-onset psoriasis: Association with future cardiovascular and metabolic comorbidities","volume":"169","author":"Mah\u00e9","year":"2013","journal-title":"Br J Dermatol"},{"key":"R22-2-20240829","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archdermatol.2009.48","article-title":"Psoriasis and the risk of diabetes and hypertension: A prospective study of US female nurses","volume":"145","author":"Qureshi","year":"2009","journal-title":"Arch Dermatol"},{"key":"R23-2-20240829","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archdermatol.2012.1401","article-title":"Increased risk of diabetes mellitus and the likelihood of receiving diabetes mellitus treatment in patients with psoriasis","volume":"148","author":"Azfar","year":"2012","journal-title":"Arch Dermatol"},{"key":"R24-2-20240829","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000381913","article-title":"Epidemiology and comorbidity in children with psoriasis and atopic eczema","volume":"231","author":"Augustin","year":"2015","journal-title":"Dermatology"},{"key":"R25-2-20240829","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/pde.13772","article-title":"A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population","volume":"36","author":"Paller","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"R26-2-20240829","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; and International association for the study of obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"R27-2-20240829","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jaad.2011.11.935","article-title":"Association between pediatric psoriasis and the metabolic syndrome","volume":"66","author":"Au","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R28-2-20240829","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/postgradmedj-2014-133188","article-title":"Clinical profile of childhood-onset psoriasis and prevalence of HLA-Cw6: A hospital-based study from India","volume":"91","author":"Sathishkumar","year":"2015","journal-title":"Postgrad Med J"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_276_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:10:47Z","timestamp":1787771447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_276_23"}},"subtitle":["Experience from a Tertiary Care Centre"],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_276_23","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}